Inborn Errors of Purine-Pyrimidine Metabolism

This refers to problems with how your body processes purines and pyrimidines. These are building blocks for DNA and RNA. Inborn errors mean these problems are caused by genetic changes you are born with. These errors can affect various parts of your body, like your blood or brain.

Condition

What people with Inborn Errors of Purine-Pyrimidine Metabolism report

Every report comes from a Lived member, sent anonymously.

Have you tried Allopurinol for Inborn Errors of Purine-Pyrimidine Metabolism?

NameHow it went

About Inborn Errors of Purine-Pyrimidine Metabolism

What It Is

Inborn errors of purine-pyrimidine metabolism are a group of rare inherited conditions in which the body cannot properly make, recycle or break down purines and pyrimidines. These are the chemical building blocks of DNA and RNA, and they also help cells store and use energy. Each disorder involves one enzyme that is missing, too weak or, in a few cases, overactive. As a result, certain substances build up to harmful levels or run short, and that imbalance produces the symptoms. This is an umbrella term for many separate disorders rather than one disease, and they can look very different from each other. Some mainly affect the kidneys, forming crystals and stones. Some weaken the immune system. Others affect the brain and nerves, causing developmental delay, seizures, low muscle tone, movement problems or hearing loss. A few cause no everyday symptoms at all. A handful of examples show the range. Lesch-Nyhan syndrome, which almost only affects boys and men, causes a large overproduction of uric acid (leading to gout-like joint pain and kidney stones) together with severe movement problems and compulsive self-injury such as lip and finger biting. Adenosine deaminase (ADA) deficiency usually causes severe combined immunodeficiency (SCID), in which a baby has almost no protection against infection. Adenine phosphoribosyltransferase (APRT) deficiency causes repeated kidney stones and can damage the kidneys over time. Dihydropyrimidine dehydrogenase (DPD) deficiency can cause neurological problems in infancy in its severe form, but many people with it feel entirely well and only learn about it when certain cancer drugs affect them severely.

Causes & Risk Factors

Each of these disorders is caused by a change (variant) in a single gene that carries the instructions for one enzyme. They are inherited and present from the start of life. They are not caused by anything a person or parent did, and diet does not bring them on. Most, including ADA, APRT and DPD deficiency, are autosomal recessive. A child is affected when they inherit a non-working copy of the gene from each parent; the parents, who each carry one copy, usually have no symptoms. Lesch-Nyhan syndrome is X-linked, meaning the gene sits on the X chromosome. That is why it almost always affects males, while women who carry the variant usually have no symptoms but can pass it to their sons. Severity depends largely on how much enzyme activity remains. A complete loss tends to cause the most serious form, while partial activity can cause milder disease. In the Lesch-Nyhan variant, for example, uric acid is high and neurological problems may occur, but self-injury does not. With DPD deficiency, even one altered copy of the gene can raise the risk of severe reactions to certain cancer drugs. People in the same family with the same variant can still be affected differently.

How It's Diagnosed

Because early signs such as developmental delay, seizures, low muscle tone or kidney stones are shared with many other conditions, these disorders are often overlooked or mistaken for something else. Children with Lesch-Nyhan syndrome, for example, are often first diagnosed with cerebral palsy. Clues that point toward a purine or pyrimidine disorder include an unusually high or low uric acid level in blood or urine, orange or reddish-brown crystals in a baby's diaper, kidney stones at a young age, unexplained anemia, or repeated serious infections in infancy. Diagnosis usually combines specialized urine or blood tests that measure purines, pyrimidines and their breakdown products, sometimes a test of the enzyme's activity in blood or skin cells, and genetic testing to find the responsible variant. Genetic testing is usually what confirms which disorder is present. Newborn screening for SCID identifies most babies with ADA deficiency before they become ill, but most other disorders in this group are not picked up by routine newborn screening. DPD deficiency is often found in a different setting: before cancer treatment with fluorouracil or capecitabine (Xeloda), two related chemotherapy drugs that the DPD enzyme normally breaks down. People with low DPD activity can have severe and sometimes fatal reactions to them. US prescribing information for capecitabine advises testing for variants in DPYD, the gene that carries the instructions for the DPD enzyme, before starting, unless treatment cannot wait. A normal result lowers the risk but does not rule out serious side effects.

Treatment Options

There is no single treatment for this group, because each disorder goes wrong in a different way. For many forms, care focuses on managing symptoms and complications, but several have specific treatments that work best when started early. When the problem is a substance that forms crystals, lowering it protects the kidneys and joints. Allopurinol, a medicine that blocks the enzyme that makes uric acid and is also used for gout, lowers uric acid in Lesch-Nyhan syndrome. In APRT deficiency, allopurinol and a related drug, febuxostat, reduce the substance that forms the stones; a small study found febuxostat lowered it further at standard doses. In Lesch-Nyhan syndrome these medicines do not improve movement problems or self-injury. Those are treated mainly with medicines aimed at specific symptoms and, for some people, deep brain stimulation, a surgically implanted device that sends electrical pulses to the brain. Research on these approaches is limited and results have been inconsistent. For ADA deficiency, the goal is to rebuild the immune system. Enzyme replacement therapy supplies the missing enzyme and can protect a child while a longer-term plan is made. A stem cell (bone marrow) transplant from a matched brother, sister or other family member is the preferred treatment. When no matched relative is available, gene therapy, which adds a working copy of the gene to the person's own blood-forming cells, or a transplant from another donor may be considered at specialized centers. Hereditary orotic aciduria, a rare pyrimidine disorder that affects blood counts, is treated with uridine triacetate, a daily medicine that replaces the pyrimidine the body cannot make. For DPD deficiency, the key step is planning around fluorouracil and capecitabine: an oncologist may lower the dose, choose a different drug, or avoid these drugs entirely when the deficiency is complete. If severe toxicity develops soon after treatment, an antidote containing uridine triacetate (Vistogard) can be given as emergency treatment. For any of these disorders, genetic counseling helps families understand how the condition is inherited and what it may mean for brothers, sisters and future children.

What to Expect

The outlook varies more across this group than for most conditions. Some people, including many with DPD deficiency or partial ADA deficiency, have no day-to-day symptoms at all. Others live with a condition that mainly needs kidney follow-up, while the most severe forms affect development from infancy and require lifelong care. APRT deficiency can show up anytime from infancy to late adulthood, and about half of people first have symptoms as adults. Without treatment, repeated stones and crystal deposits can gradually reduce kidney function, sometimes to the point of kidney failure. Treatment aims to stop new stones and keep kidney function stable, and ongoing follow-up checks whether it is working. Lesch-Nyhan syndrome is a lifelong and severe condition. Over time, most people need a wheelchair and help with personal care, and life expectancy is reduced, with kidney failure, breathing problems and pneumonia among the main complications. Because the urge to self-injure is compulsive rather than chosen, families often need practical measures to protect the person and support with daily care. ADA deficiency with SCID (ADA-SCID) is life-threatening in infancy without treatment, but outcomes have improved considerably with newborn screening, transplant and gene therapy. Even after successful treatment, long-term follow-up continues, because ADA deficiency can also affect development, behavior, hearing, the lungs and other organs. Because these disorders are rare, care is often coordinated through a genetics or metabolic clinic. For many of the neurological forms there is still no treatment that changes the underlying course, and research into causes and therapies continues.

When to Seek Help

Ask for an evaluation, ideally involving a genetics or metabolic specialist, if a child has unexplained developmental delay, seizures, low muscle tone or movement problems, especially alongside kidney stones, an unusual uric acid level, unexplained anemia, or orange or reddish-brown crystals in the diaper. Kidney stones in a child, or repeated stones in an adult without a clear cause, are also worth raising. If a close relative has one of these disorders, genetic counseling and testing can clarify your own or your children's risk. Contact the care team promptly if a baby has repeated or unusually severe infections, ongoing diarrhea or poor growth, since these can be signs of an immune deficiency such as ADA-SCID. In someone known to form stones, pain on urination, blood in the urine, fever or trouble passing urine also needs prompt attention. If you know you have DPD deficiency or a DPYD variant, make sure every oncologist knows before fluorouracil or capecitabine is considered. While taking these drugs, contact the oncology team right away for severe diarrhea, mouth sores that make it hard to eat or drink, fever or other signs of infection, or unusual bleeding.

Questions to Ask Your Doctor

  1. 1.Which specific disorder is this, and how certain is the diagnosis?
  2. 2.Is there a treatment for this form that works better when started early, and what can it realistically achieve?
  3. 3.Which organs need monitoring, such as the kidneys, immune system or hearing, and how often?
  4. 4.Should other family members be tested, and what does this mean for future pregnancies?
  5. 5.Are there medicines, including cancer drugs, that I should avoid or flag to every doctor I see?

Last reviewed • Oct 2026

Educational content, not medical advice.